SCHEMBL6846172

SCHEMBL6846172

CS(=O)(=O)N1CC2(CCC(C(=O)NC3CCN(c4cc(F)cc(F)c4)CC3)CC2)c2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 20/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6846174 1.00 NPY5R (0.55) NPY5R
SCHEMBL5468217 0.93 NPY5R (0.54) NPY5R
SCHEMBL5468218 0.93 NPY5R (0.54) NPY5R
SCHEMBL6848571 0.92 NPY5R (0.56) NPY5R
SCHEMBL6848567 0.92 NPY5R (0.56) NPY5R
SCHEMBL5482838 0.90 NPY5R (0.62) NPY5R
SCHEMBL5475272 0.90 NPY5R (0.62) NPY5R
SCHEMBL5471480 0.90 NPY5R (0.52) NPY5R
SCHEMBL5471475 0.90 NPY5R (0.52) NPY5R
SCHEMBL5483738 0.84 NPY5R (0.60) NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259890-A1 Spiro compounds MSD K.K. (JP) 2004-12-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259890-A1 Spiro compounds OPRD1, PER2, OPRK1 NPY5R 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.